Serial 98256127
Live / Registered — Registered (as of 15 Oct 2024)
What this means for you
Registered since 15 Oct 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98256127
- Registration number
- 7534160
- Mark type
- Design / logo
- Filed
- 06 Nov 2023
- Published for opposition
- 30 Jul 2024
- Registered
- 15 Oct 2024
- Attorney of record
- Michael J. Hertz
Goods and services
- Class 042 — Scientific and technological services: Research and development of pharmaceutical drugs and medicines for the treatment of infections, lung diseases, and skin diseases; Research and development in the pharmaceutical, life sciences, and biomedicine fields; Scientific research, testing, and analysis in the fields of pharmaceuticals, life science, and biomedicine; Medical and scientific research on lung diseases, skin diseases, infections, and cancer; Pharmaceutical products testing, analysis, research, and development
Owner
- Alphyn Biologics, Inc., Annapolis, MD, US
- Alphyn Biologics, Inc., Annapolis, MD, US
- Alphyn Biologics, Inc., Annapolis, MD, US
Prior registrations
Prosecution history
- 15 Oct 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 15 Oct 2024 — REGISTERED-PRINCIPAL REGISTER
- 30 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Jul 2024 — PUBLISHED FOR OPPOSITION
- 10 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Jun 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Jun 2024 — EXAMINER'S AMENDMENT ENTERED
- 25 Jun 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 25 Jun 2024 — EXAMINERS AMENDMENT E-MAILED
- 25 Jun 2024 — EXAMINERS AMENDMENT -WRITTEN
- 14 Jun 2024 — ASSIGNED TO EXAMINER
- 01 Dec 2023 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 30 Nov 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 09 Nov 2023 — NEW APPLICATION ENTERED